Liaison Technologies Recevives Investment from Merck Global Health Innovation Fund

Liaison Technologies, an Atlanta, GA-based provider of cloud-enabled data integration and data management solutions, recevived an investment from Merck Global Health Innovation Fund.

The investment, which brought total funding to $90m, will enable the company to accelerate innovation on its healthcare platform and support growth through acquisitions.

Led by Bob Renner, CEO, Liaison Technologies provides cloud-enabled data integration and data management solutions to break down complex information barriers, enabling enterprises to make smarter decisions.
Founded in 2000, the company serves over 7,000 customers in 46 countries with offices in the United States, Finland, Netherlands, Sweden and the United Kingdom.

FinSMEs

13/03/2015

Join the discussion